Seoul National University Hospital Identifies Causes of Half of Rare Genetic Diseases Through Whole Genome Sequencing
Analysis of 1,452 Korean Families Reveals Variants Missed by Conventional Tests
Some Cases Lead to Personalized Treatment
A large-scale domestic study has found that applying whole genome sequencing to patients with rare genetic diseases who could not be diagnosed through conventional genetic tests can identify the causative genetic variants in nearly half of the cases.
On January 30, Seoul National University Hospital announced that a research team led by Professors Jonghee Chae, Seungbok Lee, and Suyeon Kim from the Department of Clinical Genomic Medicine, together with Dr. Kohoon Seo's team from the genome analysis company 3billion, conducted whole genome sequencing on 1,452 Korean families (a total of 3,317 individuals) suspected of having rare genetic diseases. The study identified the cause of the disease in 46.2% of all families analyzed.
From the left, Jonghee Chae, Seungbok Lee, and Suyeon Kim, Professors of Clinical Genomics Medicine at Seoul National University Hospital. Seoul National University Hospital
View original imageAmong the 672 families in which a diagnosis was made, 14.6% had causative genetic variants identified only through whole genome sequencing. When family members were included in the analysis, the diagnostic rate was 48.5%, which was higher than the rate for testing the patient alone (41.5%).
By disease type, the diagnostic rate was relatively high for neuromuscular diseases and neurodevelopmental disorders. In 4.3% of all those tested, additional pathogenic genetic variants were found that could affect health, such as increased risk of cardiomyopathy, arrhythmia, or cancer.
Among patients whose disease cause was identified, 18.5% had long-term treatment or management plans established based on the genetic diagnosis. Personalized treatment was actually applied in clinical practice for patients with Gitelman syndrome and generalized pustular psoriasis.
The research team believes that whole genome sequencing can serve as a foundation for expanding precision medicine in the future, not only by predicting prognosis and providing family counseling for patients with rare genetic diseases, but also by enabling gene-targeted therapies.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Chae stated, "We have confirmed the clinical utility of whole genome sequencing in a large patient cohort, even among those who could not be diagnosed with conventional tests," adding, "Accurate genetic diagnosis can reduce diagnostic delays and lead to early treatment and personalized management."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.